Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Development & Bioavailability
  6.  » Concept to Dosing: Challenges in New Orphan Drugs
Icon of a document with a pencil

Concept to Dosing: Challenges in New Orphan Drugs

Summary:​ With significant market opportunity available and dedicated regulatory pathways defined, the number of orphan drug programs are growing globally. As drug developers look to address unmet medical needs for orphan diseases, working with experienced partners can help in navigating key challenges such as a limited active pharmaceutical ingredient supply, efficient small-scale manufacturing for small patient populations and distribution logistics. Read this article that shares insights from industry experts on key strategies for managing an orphan drug program.

View Whitepaper